Targeted knockdown of death-associated protein kinase expression induces TRAIL-mediated apoptosis in human endometrial adenocarcinoma cells

International Journal of Oncology

Volumn 37, Issue 1, 2010, Pages 203-210

  Bai, Tao ^a   Tanaka, Tetsuji ^a   Yukawa, Kazunori ^b  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b MEIJO UNIVERSITY   (Japan)

Author keywords

Death associated protein kinase; Endometrial adenocarcinoma; siRNA; TRAIL

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; DEATH ASSOCIATED PROTEIN KINASE; DEATH RECEPTOR 4; DEATH RECEPTOR 5; RECOMBINANT TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; ANTINEOPLASTIC AGENT; APOPTOSIS REGULATORY PROTEIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE;

APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL VIABILITY; CONTROLLED STUDY; DNA CONTENT; DOWN REGULATION; ENDOMETRIUM CARCINOMA; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RIBONUCLEASE PROTECTION ASSAY; TUMOR DIFFERENTIATION; ANTAGONISTS AND INHIBITORS; CARCINOMA, ENDOMETRIOID; DRUG EFFECTS; DRUG POTENTIATION; DRUG SCREENING; ENDOMETRIAL NEOPLASMS; FEMALE; GENE SILENCING; GENE TARGETING; GENETICS; PATHOLOGY; PHYSIOLOGY; TUMOR CELL CULTURE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES; CARCINOMA, ENDOMETRIOID; DEATH-ASSOCIATED PROTEIN KINASES; DRUG EVALUATION, PRECLINICAL; DRUG SYNERGISM; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENE TARGETING; HUMANS; RNA, SMALL INTERFERING; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 77953201672     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000668     Document Type: Article

References (30)

1. Ashkenazi A and Dixit VM: Death receptors: signaling and modulation. Science 281: 1305-1308, 1998..
2. Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A and Ashkenazi A: Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 271: 12687-12690, 1996. (Pubitemid 26175834)
3. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, Sutherland GR, Smith TD, Rauch C and Smith CA: Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3: 673-682, 1995.
4. Sheridan JP, Marsters SA, Pitti RM, Gurney A, Skubatch M, Baidwin D, Ramakrishnan L, Gray CL, Baker K, Wood WI, Goddard AD, Godowski P and Ashkenazi A: Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 277: 818-821, 1997.
5. Chaudhary PM, Eby M, Jasmin A, Bookwalter A, Murray J and Hood L: Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway. Immunity 7: 821-830, 1997. (Pubitemid 28064895)
6. Pan G, Ni J, Wei YF, Yu G, Genze R and Dixit VM: An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 277: 815-818, 1997. (Pubitemid 27366732)
7. Wu GS, Burns TF, McDonald ER, Jiang W, Meng R, Krantz ID, Kao G, Gan DD, Zhou JY, Muschel R, Hamilton SR, Spinner NB, Markowitz S, Wu G and El-Deiry WS: KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat Genet 17: 141-143, 1997.
8. Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA, Blackie C, Chang L, McMurtrey AE, Hebert A, DeForge L, Koumenis IL, Lewis D, Harris L, Bussiere J, Koeppen H, Shahrokh Z and Schwall RH: Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest 104: 155-162, 1999.
9. Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M, Chin W, Jones J, Woodward A, Le T, Smith C, Smolak P, Goodwin RG, Rauch CT, Schuh JC and Lynch DH: Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 5: 157-163, 1999. (Pubitemid 29068521)
10. Leverkus M, Neumann M, Mengling T, Rauch CT, Brocker EB, Krammer PH and Walczak H: Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes. Cancer Res 60: 553-559, 2000. (Pubitemid 30094550)
11. Ichikawa K, Liu W, Zhao L, Wang Z, Liu D, Ohtsuka T, Zhang H, Mountz JD, Koopman WJ, Kimberly RP and Zhou T: Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity. Nat Med 7: 954-960, 2001.
12. Hao C, Beguinot F, Condorelli G, Trencia A, van Meir EG, Yong VW, Parney IF, Roa WH and Petruk KC: Induction and intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apoptosis in human malignant glioma cells. Cancer Res 61: 1162-1170, 2001. (Pubitemid 32174439)
13. Nicholson DW and Thornberry NA: Life and death decisions. Science 299: 214-215, 2003.
14. Gross A, Yin XM, Wang K, Wei MC, Jockel J, Milliman C, Erdjument-Bromage H, Tempst P and Korsmeyer SJ: Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death. J Biol Chem 274: 1156-1163, 1999. (Pubitemid 129535271)
15. Li H, Zhu H, Xu CJ and Yuan J: Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94: 491-501, 1998. (Pubitemid 28391865)
16. Deiss LP, Feinstein E, Berissi H, Cohen O and Kimchi A: Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the gamma interferon-induced cell death. Genes Dev 9: 15-30, 1995.
17. Cohen O, Feinstein E and Kimchi A: DAP kinase is a Ca2+/calmodulin- dependent, cytoskeleton-associated protein kinase, with cell death-inducing functions that depend on its catalytic activity. EMBO J 16: 998-1008, 1997. (Pubitemid 27113179)
18. Cohen O, Inbal B, Kissil JL, Raveh T, Berissi H, Spivak-Kroizaman T, Feinstein E and Kimchi A: DAP kinase participates in TNF-alpha- and Fas-induced apoptosis and its function requires the death domain. J Cell Biol 146: 141-148, 1999. (Pubitemid 29349970)
19. Jang CW, Chen CH, Chen CC, Chen JY, Su YH and Chen RH: TGFβ induces apoptosis through Smad-mediated expression of DAP kinase. Nat Cell Biol 4: 51-58, 2002.
20. Raveh T, Droguett G, Horwitz MS, De Pinho RA and Kimchi A: DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation. Nat Cell Biol 3: 1-7, 2001.
21. Pelled D, Raveh T, Riebeling C, Fridkin M, Berissi H, Futerman AH and Kimchi A: Death-associated protein (DAP) kinase plays a central role in ceramide induced apoptosis in cultured hippocampal neurons. J Biol Chem 277: 1957-1961, 2002.
22. Yamamoto M, Hioki T, Nakajima-Iijima S and Uchino S: DAP kinase activity is critical for C (2)-ceramide-induced apoptosis in PC12 cells. Eur J Biochem 269: 139-147, 2002. (Pubitemid 34107347)
23. Wang WJ, Kuo JC, Yao CC and Chen RH: DAP kinase induces apoptosis by suppressing integrin activity and disrupting matrix survival signals. J Cell Biol 159: 169-179, 2002.
24. Kissil JL, Feinstein E, Cohen O, Jones PA, Tsai YC, Knowles MA, Eydmann ME and Kimchi A: DAP kinase loss of expression in various carcinoma and B-cell lymphoma cell lines: possible implications for role as tumor suppressor gene. Oncogene 15: 403-407, 1997. (Pubitemid 27370989)
25. Inbal B, Cohen O, Polak-Charcon S, Kopolovic J, Vadai E, Eisenbach L and Kimchi A: DAP kinase links the control of apoptosis to metastasis. Nature 390: 180-184, 1997. (Pubitemid 27507988)
26. Jin Y, Blue EK, Dixon S, Hou L, Wysolmerski RB and Gallagher PJ: Identification of a new form of death-associated protein kinase that promotes cell survival. J Biol Chem 276: 39667-39678, 2001.
27. Jin Y and Gallagher PJ: Antisense depletion of death-associated protein kinase promotes apoptosis. J Biol Chem 278: 51587-51593, 2003.
28. Bai T, Tanaka T, Yukawa K and Umesaki N: Reduced expression of death-associated protein kinase in human uterine and ovarian carcinoma cells. Oncol Rep 11: 661-665, 2003.
29. Ishiwata I, ishiwata C, Soma M, Arai J and Ishikawa H: Establishment of human endometrial adenocarcinoma cell line containing estradiol-17 beta and progesteron receptors. Gynecol Oncol 17: 281-290, 1984.
30. Nalgane M, Pan G, Weddle JJ, Dixit VM, Cavenee WK and Huang HJ: Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo. Cancer Res 60: 847-853, 2000. (Pubitemid 30129513)